España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Adial Pharmaceuticals
ADIL
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.07
0.02
1.90%
At close: -
$1.05
-0.02
-1.87%
After Hours: 7:48 PM EDT
Get Report
Comment
Adial Pharmaceuticals (ADIL) Forecast
News
Earnings
Adial Pharmaceuticals (ADIL) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Adial Pharmaceuticals (NASDAQ:ADIL) Stock
Adial Pharmaceuticals Stock (NASDAQ: ADIL)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, December 03, 2024
EXCLUSIVE: Adial Pharmaceuticals' Lead Drug Secures Key US Patent For Alcohol Dependence Based on Expanded Genotype Combinations
Vandana Singh
EXCLUSIVE: Adial Pharmaceuticals Tells Benzin...
Benzinga Newsdesk
EXCLUSIVE: Adial Pharmaceuticals Tells Benzin...
Benzinga Newsdesk
Thursday, November 14, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Adial Pharmaceuticals shares are trading high...
Benzinga Newsdesk
EXCLUSIVE: Adial Pharmaceuticals Reveals Topline Results From Pharmacokinetics Study Of AD04 For Alcohol Use Disorder
Vandana Singh
EXCLUSIVE: Adial Pharmaceuticals Tells Benzin...
Benzinga Newsdesk
EXCLUSIVE: Adial Pharmaceuticals Tells Benzin...
Benzinga Newsdesk
EXCLUSIVE: Adial Pharmaceuticals Tells Benzin...
Benzinga Newsdesk
EXCLUSIVE: Adial Pharmaceuticals Tells Benzin...
Benzinga Newsdesk
This Turning Point Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Avi Kapoor
Rodman & Renshaw Initiates Coverage On Adial ...
Benzinga Newsdesk
Wednesday, November 13, 2024
Adial Pharmaceuticals Q3 Net Loss $2.2M
Benzinga Newsdesk
Tuesday, November 05, 2024
Adial Pharmaceuticals Appoints Vinay Shah As ...
Benzinga Newsdesk
Thursday, October 17, 2024
EXCLUSIVE: Adial Pharmaceuticals Secures Additional US Patent Expanding Intellectual Property Protection Around Its Alcohol Use Disorder Candidate
Vandana Singh
EXCLUSIVE: Adial Pharmaceuticals Tells Benzin...
Benzinga Newsdesk
EXCLUSIVE: Adial Pharmaceuticals Tells Benzin...
Benzinga Newsdesk
Thursday, September 19, 2024
Adial Pharmaceuticals Announces Database Lock...
Benzinga Newsdesk
Wednesday, August 14, 2024
Adial Pharmaceuticals Q2 EPS $(0.59) Up From ...
Benzinga Newsdesk
Tuesday, August 13, 2024
EXCLUSIVE: Adial Pharmaceuticals Advances Regulatory Strategy For Companion Diagnostic Genetic Test For Its Lead Program For Alcohol Use Disorder
Vandana Singh
EXCLUSIVE: Adial Pharmaceuticals Tells Benzin...
Benzinga Newsdesk
EXCLUSIVE: Adial Pharmaceuticals Tells Benzin...
Benzinga Newsdesk
Wednesday, August 07, 2024
EXCLUSIVE: Adial Pharmaceuticals' Last Patient Dosed in Pharmacokinetics Study of AD04 For Alcohol Use Disorder, Data Expected In Q4
Vandana Singh
EXCLUSIVE: Adial Pharmaceuticals Tells Benzin...
Benzinga Newsdesk
EXCLUSIVE: Adial Pharmaceuticals Tells Benzin...
Benzinga Newsdesk
Wednesday, July 31, 2024
Adial Pharmaceuticals shares are trading high...
Benzinga Newsdesk
Adial Pharmaceuticals Files New Patent Applic...
Benzinga Newsdesk
Tuesday, July 23, 2024
Gold Moves Higher; Coca-Cola Increases FY24 Forecast
Avi Kapoor
Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Crude Oil Down 2%; GE Aerospace Earnings Top Views
Avi Kapoor
US Stocks Edge Higher; General Motors Posts Upbeat Earnings
Avi Kapoor
Adial Pharmaceuticals shares are trading high...
Benzinga Newsdesk
EXCLUSIVE: Milestone Scientific Tells Benzing...
Benzinga Newsdesk
EXCLUSIVE: Adial Pharmaceuticals Moves Forward To Second Cohort In Pharmacokinetics Study of AD04 For Alcohol Use Disorder
Vandana Singh
EXCLUSIVE: Adial Pharmaceuticals Tells Benzin...
Benzinga Newsdesk
EXCLUSIVE: Adial Pharmaceuticals Tells Benzin...
Benzinga Newsdesk
Thursday, June 20, 2024
EXCLUSIVE: Adial Pharmaceuticals Announces Publication In Journal Supporting the Potential Efficacy Of AD04 For Alcohol Use Disorder
Vandana Singh
Wednesday, June 05, 2024
Adial Pharmaceuticals shares are trading high...
Benzinga Newsdesk
EXCLUSIVE: Adial Pharmaceuticals Starts Patient Dosing In Pharmacokinetics Study Of AD04 For Alcohol Use Disorder
Vandana Singh
Friday, May 24, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Wednesday, May 15, 2024
Adial Pharmaceuticals Q1 EPS $(2.19) Misses $...
Benzinga Newsdesk
Thursday, April 25, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Monday, April 22, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
EXCLUSIVE: Alcohol Disorder Focused Adial Pharmaceuticals Secures US Patent
Vandana Singh
EXCLUSIVE: Adial Pharmaceuticals Tells Benzin...
Benzinga Newsdesk
EXCLUSIVE: Adial Pharmaceuticals Tells Benzin...
Benzinga Newsdesk
Wednesday, April 17, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Monday, April 15, 2024
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Friday, April 12, 2024
Adial Pharmaceuticals Files Prospectus Relate...
Benzinga Newsdesk
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch